Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer.

Autor: Kınıkoğlu O; Department of Medical Oncology, Health Science University, Kartal Dr. Lütfi Kirdar City Hospital, İstanbul 34865, Türkiye., Öven BB; Department of Medical Oncology, Yeditepe University Medical Faculty, İstanbul 34718, Türkiye., Çelik S; Department of Medical Oncology, Yeditepe University Medical Faculty, İstanbul 34718, Türkiye., Alan Selçuk N; Department of Nuclear Medicine, Yeditepe University Medical Faculty, İstanbul 34718, Türkiye., Beydağı G; Department of Nuclear Medicine, Yeditepe University Medical Faculty, İstanbul 34718, Türkiye., Akçay K; Department of Nuclear Medicine, Yeditepe University Medical Faculty, İstanbul 34718, Türkiye., Kabasakal L; Department of Nuclear Medicine, Istanbul University Cerrahpaşa Medical Faculty, İstanbul 34098, Türkiye.

Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Aug 06; Vol. 13 (16). Date of Electronic Publication: 2024 Aug 06.

Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group.

Autor: Gürbüz M; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey. mgurbuz@ankara.edu.tr., Kutlu Y; Department of Medical Oncology, Faculty of Medicine, İstanbul Medipol University, Istanbul, Turkey., Akkuş E; Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara, Turkey., Köksoy EB; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Köse N; Department of Medical Oncology, Memorial Ankara Hospital, Ankara, Turkey., Öven BB; Department of Medical Oncology, Faculty of Medicine, Bahçeşehir University, Göztepe Medical Park Hospital, Istanbul, Turkey., Uluç BO; Department of Medical Oncology, Acıbadem Altunizade Hospital, Istanbul, Turkey., Demiray AG; Department of Medical Oncology, Faculty of Medicine, Pamukkale University, Denizli, Turkey., Erdem D; Department of Medical Oncology, Samsun Medical Park Hospital, Samsun, Turkey., Demir B; Department of Medical Oncology, Faculty of Medicine, Aydın Adnan Menderes University, Aydın, Turkey., Turhal NS; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Üskent N; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Akbaş S; Department of Medical Oncology, Koç University Hospital, Istanbul, Turkey., Selçukbiricik F; Department of Medical Oncology, Koç University Hospital, Istanbul, Turkey., İnal A; Department of Medical Oncology, Mersin City Hospital, Mersin, Turkey., Bilici A; Department of Medical Oncology, Faculty of Medicine, İstanbul Medipol University, Istanbul, Turkey., Ölmez ÖF; Department of Medical Oncology, Faculty of Medicine, İstanbul Medipol University, Istanbul, Turkey., Çabuk D; Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey., Ünal Ç; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey., Hızal M; Department of Medical Oncology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey., Şendur MAN; Department of Medical Oncology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey., Korkmaz M; Meram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Karadurmuş N; Department of Medical Oncology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey., Ertürk İ; Department of Medical Oncology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey., Göksu SS; Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey., Tatlı AM; Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey., Güven DC; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Kılıçkap S; Department of Medical Oncology, Faculty of Medicine, İstinye University, Liv Ankara Hospital, Ankara, Turkey., Paksoy N; Department of Medical Oncology, Faculty of Medicine, İstanbul University, Istanbul, Turkey., Aydıner A; Department of Medical Oncology, Faculty of Medicine, İstanbul University, Istanbul, Turkey., Çınkır HY; Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey., Özkul Ö; Department of Medical Oncology, Bağcılar Training and Research Hospital, Istanbul, Turkey., Öztürk A; Department of Medical Oncology, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey., Ballı S; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Kemal Y; Department of Medical Oncology, Samsun Medical Park Hospital, Samsun, Turkey., Erdoğan AP; Department of Medical Oncology, Manisa Celal Bayar University Faculty of Medicine, Manisa, Turkey., Er Ö; Department of Medical Oncology, Maslak Acıbadem Hospital, Istanbul, Turkey., Yumuk PF; Department of Medical Oncology, Koç University Hospital, Istanbul, Turkey., Demirkazık A; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2022 Dec; Vol. 148 (12), pp. 3547-3555. Date of Electronic Publication: 2022 Jun 11.

Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Autor: Dülgar Ö; Department of Medical Oncology, Göztepe Training and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey., Öven BB; Department of Medical Oncology, Faculty of Medicine, Yeditepe University, Istanbul, Turkey., Atcı MM; Department of Medical Oncology, İstanbul Prof Dr Cemil Taşcıoğlu City Hospital, Istanbul, Turkey., Arıkan R; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Ay S; Department of Medical Oncology, Göztepe Training and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey., Ayhan M; Department of Medical Oncology, Kartal Dr Lütfi Kirdar City Hospital, Istanbul, Turkey., Selvi O; Department of Medical Oncology, İstanbul Prof Dr Cemil Taşcıoğlu City Hospital, Istanbul, Turkey., Ozyukseler DT; Department of Medical Oncology, Kartal Dr Lütfi Kirdar City Hospital, Istanbul, Turkey., Bayram E; Department of Medical Oncology, Faculty of Medicine, Çukurova University, Adana, Turkey., Özcan E; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Yasin Aİ; Department of Medical Oncology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey., Gümüş M; Department of Medical Oncology, Göztepe Training and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey.; Department of Medical Oncology, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Turkey.

Publikováno v: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2022 Jul; Vol. 22 (7), pp. 773-780. Date of Electronic Publication: 2022 Jun 01.

Isolated Pituitary Metastasis of Renal Cell Carcinoma: A Case Report and Systematic Review of the Literature.

Autor: Öven BB; Department of Oncology, Bahçeşehir University School of Medicine, Göztepe Medical Park Training and Education Hospital, Istanbul, Turkey., Demir MK; Department of Radiology, Bahçeşehir University School of Medicine, Göztepe Medical Park Training and Education Hospital, Istanbul, Turkey., Çelik S; Department of Oncology, Bahçeşehir University School of Medicine, Göztepe Medical Park Training and Education Hospital, Istanbul, Turkey., Moujawaz R; Medical Student, Bahçeşehir University School of Medicine, Istanbul, Turkey., Somay A; Department of Pathology, Fatih Sultan Mehmet Training and Education Hospital, Istanbul, Turkey., Kılıc T; Department of Neurosurgery, Bahçeşehir University School of Medicine, Göztepe Medical Park Training and Education Hospital, Istanbul, Turkey.

Publikováno v: Current medical imaging [Curr Med Imaging] 2022; Vol. 18 (13), pp. 1426-1432.

Frequency of HCV infection in renal cell carcinoma patients.

Autor: Budakoğlu B; Department of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey., Aksoy S, Arslan Ç, Üyetürk Ü, Babacan NA, Özcan MF, Yıldız R, Öven BB, Özdemir NY, Dizdar Ö, Büyükberber S, Akıncı MB, Türker I, Öksüzoğlu B, Altundag K, Zengin N

Publikováno v: Medical oncology (Northwood, London, England) [Med Oncol] 2012 Sep; Vol. 29 (3), pp. 1892-5. Date of Electronic Publication: 2011 Apr 03.